Welcome!

News Feed Item

Omega-3 Polyunsaturated Fatty Acids (PUFAs) - A Global Market Overview

NEW YORK, Feb. 24, 2014 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Omega-3 Polyunsaturated Fatty Acids (PUFAs) - A Global Market Overview
http://www.reportlinker.com/p02029889/Omega-3-Polyunsaturated-Fatty-Acid...

`Pharmaceutical drugs, by default, have started incorporating higher concentrations of omega-3 and it is anticipated that, over the coming few years, several new companies would be jumping on to the bandwagon of omega-3 drugs. Several drugs are in Phase II or Phase III clinical trials, with several more expected to come on-stream quite soon. However, the coming year or two is likely to witness an influx of new companies invading the global omega-3 market, provided they obtain the USFDA's or other relevant authorities' approvals.

In a global scenario where increasing attention is being directed towards issues of sustainability and limited food supplies, algal sources offer immense scope for the rapidly expanding omega-3 market to continue in the same vein. The focus on obtaining EPA and DHA from algae was prompted by an endeavor to seek out more sustainable sources, since EPA and DHA are naturally contained in algae. Moreover, the omega-3 content in fish and krill originates from their consuming the algae directly or other creatures that feed on algae. In addition to being sustainable, algae also allows for farming that can be of help in putting up desirable labels, such as "vegetarian," "kosher" or even "organic."

The past several decades have been witness to research studies that have underscored the significance of omega-3 fatty acids in maintaining heart health, in addition to safeguarding against cancer and birth defects and offsetting symptoms of diabetes, arthritis, cognitive decline, depression and several other conditions. Omega-3 Polyunsaturated Fatty Acids (PUFAs) have been growing and continues to grow significantly in the future, attributed to the above benefits.

The report reviews, analyses and projects the market of marine and algal omega-3 polyunsaturated fatty acid ingredients for global and the regional markets including North America, Europe, Asia-Pacific and Rest of World. The regional markets further analyzed for 13 independent countries across North AmericaThe United States and Canada; EuropeGermany, France, Italy, Spain, Norway, Denmark, The United Kingdom and Rest of Europe; Asia-PacificChina, Japan, South Korea, India and Rest of Asia-Pacific.

Omega-3 Polyunsaturated Fatty Acid (PUFAs) ingredients market analyzed in this study include EPA and DHA omega-3s from marine oils such as fish oils, krill oils and squid oils; and algal oils. The end use application markets covered in the report include dietary supplements, food & beverages, pet nutrition, infant nutrition, pharmaceuticals and clinical nutrition. Worldwide, consumption of Omega-3 polyunsaturated fatty acids (PUFAs), estimated at 123.8 thousand metric tons worth US$2.3 billion in 2013, is forecast to be 134.7 thousand metric tons valued at US$2.5 billion in 2014. By 2020, it is projected that demand for Omega-3 PUFAs globally would reach 241 thousand metric tons with a value of US$4.96 billion, thereby posting a volume CAGR of almost 10% and a value CAGR of 11.6% between 2013 and 2020.

This 410 page global market report includes 126 charts (includes a data table and graphical representation for each chart), supported with meaningful and easy to understand graphical presentation, of market numbers. The statistical tables represent the data for the global omega-3 ingredients market volume in metric tons and value in US$ by geographic region, the product segment and application area. This study profiles 42 key global players and 106 major players across North America – 29; Europe – 35; Asia-Pacific – 30 and Rest of World – 12. The report also provides the listing of the companies engaged in the manufacturing and supply of omega-3 PUFAs as well as major players in the omega-3 end-use industries such as human nutrition, pet nutrition and pharmaceuticals and major ingredient distributors across the globe. The global list of companies covers addresses, contact numbers and the website addresses of 294 companies.
PART A: GLOBAL MARKET PERSPECTIVE

1. INTRODUCTION
1.1 Product Outline
1.1.1 What is Omega-3?
1.1.1.1 Fatty Acids
1.1.1.1.1 Saturated Fatty Acids
1.1.1.1.2 Unsaturated Fatty Acids
1.1.1.1.3 Polyunsaturated Fatty Acids (PUFAs)
1.1.1.2 Omega-3 Fatty Acids
1.1.1.2.1 Categories of Omega-3 Fatty Acids
1.1.1.2.1.1 Short Chain Omega-3 Fatty Acids
1.1.1.2.1.1.1 Alpha-Linolenic Acid (ALA)
1.1.1.2.1.2 Long Chain Omega-3 Fatty Acids (LC-PUFAs)
1.1.1.2.1.2.1 Docosahexaenoic Acid (DHA)
1.1.1.2.1.2.2 Eicosapentaenoic Acid (EPA)
1.1.2 Dietary Sources of Omega-3 Fatty Acids
1.1.3 Omega-3 and Its Health Benefits
1.2 Evolution of Raw Material Sources for Omega-3 Polyunsaturated Fatty Acids (PUFAs)
1.2.1 Marine Oils
1.2.1.1 Fish Oil
1.2.1.2 Krill Oil
1.2.1.3 Other Marine Sources
1.2.2 Algae
1.2.3 Plants
1.3 Evolution of Omega-3 Fatty Acid Ingredient Forms
1.3.1 First Generation Omega-3 Forms
1.3.2 Second Generation Omega-3 Forms
1.3.3 Third Generation Omega-3 Forms
1.4 Omega-3 PUFA Ingredient Type Analysis
1.4.1 18/12 (30% omega-3) Fish Oils
1.4.2 Cod Liver Oils
1.4.3 Tuna Oils
1.4.4 Salmon Oils
1.4.5 Omega-3 Low Concentrate (40% to 55%) PUFAs
1.4.6 Omega-3 Medium Concentrate (60% to 80%) PUFAs
1.4.7 Omega-3 High Concentrate (above 85%) PUFAs
1.4.8 Krill Oils
1.4.9 Algal Oils
1.4.10 Other Omega-3 PUFAs
1.5 Omega-3 PUFA End-Use Application Analysis
1.5.1 Dietary Supplements
1.5.2 Pet Nutrition
1.5.3 Food & Beverages
1.5.4 Infant Nutrition
1.5.5 Pharmaceuticals
1.5.6 Clinical Nutrition
1.6 Manufacturing Processes for Omega-3 Fatty Acids
1.6.1 Chemistry of Omega-3 Fatty Acids
1.6.2 Processing of Fish Oils
1.6.3 Decontamination
1.6.4 Concentration Process
1.6.5 Production Technologies Used for Omega-3 Fatty Acid Concentrates
1.6.5.1 Chromatographic Methods
1.6.5.2 Distillation Method
1.6.5.3 Molecular Distillation (MD)
1.6.5.4 Low-Temperature Crystallization
1.6.5.5 Urea Complexation/Precipitation
1.6.5.6 Enzymatic Methods
1.6.5.6.1 Lipase-Catalyzed Hydrolysis
1.6.5.6.2 Lipase-Catalyzed Esterification
1.6.5.7 Supercritical Fluid Technology (SFT)
1.6.5.7.1 Supercritical Fluid Extraction (SFE)
1.6.5.7.2 Supercritical Fluid Chromatography (SFC)

2. GLOBAL REGULATORY LANDSCAPE FOR OMEGA-3 FATTY ACIDS
2.1 Recommendations for Omega-3 Fatty Acids (EPA and DHA) Intake
2.2 Health Claim Approvals
2.2.1 FDA Approved Health Claim
2.2.2 New European Health Claim Regulation Becomes Effective
2.2.2.1 EU Approves Omega-3 Heart Health Claims
2.2.3 Approved Health Claims in Other Regions
2.2.3.1 Canada
2.2.3.2 Australia and New Zealand
2.2.3.3 Japan
2.3 Pharmaceutical Omega-3 Drugs Approvals
2.4 Regulations and Standards for Fish oils

3. KEY MARKET TRENDS
3.1 Consumer Demand and Pharma Pipeline to Bolster Market for Highly Concentrated Omega-3 Ingredients
3.2 Microalgae Strains Current Bestsellers as New Sources of Long Chain Omega-3 PUFAs
3.2.1 Microalgae Production
3.2.2 Microalgae as Sources of n-3 LC-PUFA
3.2.3 Algae Oil Extraction
3.3 Ethyl Ester Forms of Omega-3 Being Overtaken in Popularity by Triglyceride Forms
3.4 Study Linking Prostrate Cancer with Omega-3 Intake Leaves US Market Dismal

4. INDUSTRY STRUCTURE AND COMPETETIVE LANDSCAPE
4.1 Global Omega-3 PUFAs Industry Supply Chain Overview
4.2 Global Omega-3 PUFAs Competitive Landscape
4.3 Global Omega-3 PUFAs Installed Capacities
4.3.1 Fish Oil Sourced Omega-3 PUFAs
4.3.2 Algal Oil Sourced Omega-3 PUFAs
4.3.3 Krill Oil Sourced Omega-3 PUFAs
4.4 Omega-3 PUFA Ingredient Prices, Applications and Value Proposition

5. KEY GLOBAL PLAYERS
Aker Biomarine AS
Algae Biosciences Corporation
Aurora Algae, Inc.
Austral Group S.A.A.
Ayanda AS
BASF SE
Pronova BioPharma ASA
BASF Pharma (Callanish) Limited
BASF AS
Berg Lipidtech As (BLT)
BTSA Biotecnologías Aplicadas S.L
Cellana Inc.
Chemport, Inc.
Croda International Plc
Denomega Pure Health
Enzymotec Ltd.
EPAX AS
Felda IFFCO LLC
GC Rieber Oils
Golden Omega SA
Guangdong Runke Bioengineering Co Ltd
Huatai Biopharm Inc.
Hubei Fuxing Biotechnology Co Ltd
Jiangsu Auqi Marine Biotechnology Co., Ltd.
KD-Pharma GmbH
Lonza Group Ltd
LYSI hf.
Marine Ingredients
Maruha Nichiro Foods Inc.
Neptune Technologies & Bioressources Inc.
Acasti Pharma Inc.
Nippon Suisan Kaisha, Ltd. (Nissui)
Olvea Fish Oils (Olvea Group)
Omega Protein Corp.
InCon Processing LLC
Cyvex Nutrition, Inc.
Pharma Marine AS
Polaris Nutritional Lipids
Qualitas Health Inc
Royal DSM NV
Seven Seas Ltd
Sinomega Biotech Engineering Co Ltd
Smit Functional Oils (Smit & Zoon Group)
Solutex GC, S.L.
Source-Omega LLC
Stepan Company
TASA Omega SA (Tecnológica De Alimentos SA)
Zhejiang Shenzhou Marine Bio-Tech Co Ltd

6. KEY BUSINESS TRENDS
Enzymotec Ltd. Broadened its Migdal Ha'Emeq Production Unit
Qponics Invests $5.5 million to Produce Algae-based Omega-3 oils
Enzymotec Ltd. Partners with Polar Omega A/S to Commercialize Omega PC™
Nutegrity™, New Business Name of Omega Protein's Human Nutrition Division
Neptune and Rimfrost Enter into Supply Agreement
Scoular and Arctic Nutrition Combine Forces to Offer Romega™
GC Rieber Oils Selects Novel Ingredient Services as Exclusive Distributor
Omega Protein Corp Expands Production Capacity of Specialty Dairy Proteins
Acasti Enters into Manufacturing Alliance
FMC Corporation Takes Over Epax AS
Biosearch Life's Plants Get Halal Certification
Solutions4CO2 Inc and Quinlan Brothers Ltd Form a Joint Venture
Bioseutica Divests Omega-3 Business to German Equity Firm Capiton
SeaDragon on a Capacity Expansion Spree
Qualitas Health and Valicor Renewables Enter into an Alliance
Golden Omega Recognized as a "Responsible" Supplier Of Omega-3 Fish Oils by IFFO
BASF Acquires Pronova BioPharma ASA
Tasa to Commence Concentrated Omega Oil Production in Peru
Algae Production Facility Acquired by Solarvest BioEnergy Inc
Amarin Includes Slanmhor Pharmaceutical Inc into its Global Supply Chain
Qponics and Nutrition Care Pharmaceuticals Sign a Memorandum of Understanding (MoU)
Aurora Algae Obtains US$2.01 Million Grant
Royal DSM Takes Over Ocean Nutrition Canada
Grain Millers, Inc Takes Over Milling Assets of ENRECO, Inc
Equateq Ltd Acquired by BASF
Stauber Performance Ingredients Takes Over Pharmline
Neptune Mass Markets NKO® Premium Krill Oil through Jamieson Laboratories
AlgiSys Successful in Raising US$2.5 Million
Phase-I Facility Expansion Initiated by Neptune at Sherbrooke
Photonz Corp Transfers Fermentation Process to a Canadian Contract Facility
Pfizer Acquires Ferrosan's Consumer Health Operations
Golden Omega's Omega-3 Concentrate Plant Granted Environmental Approval
Cargill and BASF Plant Science in Collaboration for Developing EPA/DHA Canola Oil
Lipid Technologies Retained as Strategic Consultant by Omega Protein
EID Parry Acquires Valensa
GC Rieber Oils Sets Up North American Office
Omega Protein Acquires InCon Processing LLC
Photonz and Novaesp Form an Alliance
Hofseth Biocare's First Processing Facility in Midsund, Norway Inaugurated
Hofseth Biocare Appoints TSI Health Sciences as Distributor
Neptune Reinforces Asian Operations by Entry into Indian Market
Stepan Takes Over Select Product Lines from Lipid Nutrition BV
Minami Nutrition Grants Distribution Rights to Garden of Life LLC
Worldwide Supply Network for AMR101 Formed by Amarin
Photonz Corp and Separax SAS Sign an Agreement
Enzymotec and Lupin Sign a Contract
Ocean Nutrition Canada and Wilmar International Enter into Strategic Agreement
Royal DSM Acquires Martek Biosciences Corp
Omega Protein Acquires Cyvex Nutrition
Minami Nutrition Acquired by Atrium Innovations
Omega-3 Concentration Facility Inaugurated by GC Rieber Oils
Polaris Acquires Ocean Nutrasciences
Aurora Algae's Operations Extended to Perth, Australia
Pizzey's Nutritionals Rebranded as Glanbia Nutritionals
Oxford Nutrascience and Ocean Nutrition Canada Sign an Agreement
China Grants Approval for Food Use of Omega-3
Aker BioMarine and Lindsay Goldberg in an Equal Joint Venture
Twin Rivers Technologies Acquired by Felda IFFCO Sdn Bhd, Renamed FINA LLC

7. KEY PRODUCT/TECHNOLOGY TRENDS
Novel 100% Canadian Omega-3 Rich Camelina Sativa Oil from Biodroga Inc
Enzymotec's K-REAL® Krill Oil Certified by "New Food Raw Material"
LYSI Starts the Supply of FoS-Certified Omega-3 Oil
Neptune Certified by "New Food Raw Material" in China
Investigational New Drug Submission of Acasti Receives FDA Approval for its PK trial of CaPre®
"New Food Raw Material" Certification for Aker BioMarine's Superba™ Krill
Application Submitted by Rothamsted Research to DEFRA for Producing Omega-3 from GM Camelina Sativa
Croda Received IFOS™ 5-Star Supplier Certification for its Incromega™
Omega3 Innovations' Omega Heaven Receives 2013 Supply Side Editors Choice Award
DSM Unveils Algal Omega-3 Oil
First Swedish Algal Omega-3 Oil Launched by Simris
Ecoduna Develops and Tests Bioreactor Prototype for Industrial Production of Microalgae
Source-Omega Launches POWER OMEGA™ Omega-3 Mini Softgel
PURE ONE® DHAlicious™ Omega-3 Chromista Oil Product Introduced by Source-Omega
GC Rieber Oils Launches VivoMega Line of Products in Asia
Omega-3 Products Launched by Nordic Naturals in Quebec
Qualitas Health Targets Commercial Quantities of Omega-3 Fatty Acids at Imperial, Texas Facility
Solarvest Bioenergy Inc Files Application for US Patent
Researchers Extract Omegas 3, 6 and 9 from Microalgae
BASF Unveils Newtrition™ Human Nutrition Brand
Omegatri Develops World's First Compressible Omega-3 Tablets to be Launched by Lysi HF
Taisho Pharmaceutical Introduces Epadel T
Amundsen Omega-3 Obtains Friend of the Sea Seal of Approval
Valensa International Launches Perilla Seed-Based Omega-3 Fatty Acid
AquaKrill Oil ™ Liquid Krill Oil Introduced by Azantis
Ayanda Revolutionizes Intake of Fish Oil by Humans
Oceans Omega's Omega Infusion™ Water Enhanced with Omega-3 Now in Giant Food Stores
Arctic Nutrition Innovates Omega-3 Extraction
EID Parry Targeting OTC Segment in India
Amarin Corp's Fish Oil Capsules Granted FDA Approval for Hypertriglyceridemia Patients
Cellana Introduces New Range of Algal Omega-3 Products
Omega-3 Product Targeting Women Introduced by Polaris Lipid Nutrition
OmeGo™ Salmon Oil Launched by Hofseth Biocare in the United States
Liver Lipid Metabolism Found to Improve by Krill Powder in Inflammation Prototype
Veda-Vida Innovations Introduces Omega-3 in High-Dose Powder Forms
Golden Omega Introduces New Range of Omega-3 Products
Pronova Marks Entry into the Omega-3 Supplements Sector
Golden Omega Showcases Products for the United States Market
Pharma Marine Introduces Oceans Omega-3 Ingredient Family
Enzymotec Debuts K*REAL Real Krill Oil
Hofseth Biocare to Commence Supply of Omega-3 with "24 Hour Virgin Oil" Salmon
Ascenta Launches NutraSea DHA
Organic Fat-Free Milk plus DHA Omega-3 Introduced by Horizon®
Neptune's NKO® Gets Approval from Health Canada
New Clinical Study Published by Aker BioMarine Pertaining to Superba™ Krill Oil
Results from DuPont Study on Omega-3 from GM Yeast Out
Eau Plus' Omega-3 from Algae Cynosure of Several Manufacturers
SourceOne and FINA Unveil Proprietary Technology for Omega-3 Emulsions
Cargill Launches Clear Valley® Omega-3 Oil
NutraVege Vegetarian Omega-3 Vegetarian Supplement Unveiled by Ascenta
Pharma Marine Group Launches Calamarine™ Sustainable Marine-Source DHA
Cenestra Health Obtains Omega-3 Formulations Patent

8. GLOBAL MARKET OVERVIEW
8.1 Global Omega-3 PUFAs Market Overview by End-Use Application
8.2 Global Omega-3 PUFAs Market Overview by Major Raw Material Source
8.3 Global Omega-3 PUFAs Market Overview by Ingredient Type

PART B: REGIONAL MARKET PERSPECTIVE
1. Global Omega-3 PUFAs Market Overview by Geographic Region
2. Global Marine Omega-3 PUFAs Market Overview by Geographic Region
3. Global Algal Omega-3 PUFAs Market Overview by Geographic Region
4. Global Omega-3 PUFAs End-Use Application Market Overview by Geographic Region
4.1 Dietary Supplements
4.2 Pet Nutrition
4.3 Food & Beverages
4.4 Infant Nutrition
4.5 Pharmaceuticals
4.6 Clinical Nutrition

REGIONAL MARKET OVERVIEW

1. NORTH AMERICA
1.1 North American Omega-3 PUFAs Market Analysis by Major Raw Material Source
1.2 North America Omega-3 PUFAs Market Overview by Region
1.3 North America Omega-3 PUFAs Market Overview by End-Use Application
1.4 Major Market Players
Algae Biosciences Corporation (United States)
Algaentis, Inc (United States)
ALGisys LLC (United States)
Aurora Algae, Inc. (United States)
Biodroga Inc. (Canada)
Bioprocess Algae, LLC (United States)
Bioriginal Food & Science Corporation (Canada)
Cellana Inc. (United States)
Connoils LLC (United States)
Felda IFFCO LLC (United States)
Heliae Development LLC (United States)
Marine Ingredients (United States)
Neptune Technologies & Bioressources Inc. (Canada)
Nordic Naturals, Inc. (United States)
Novotech Nutraceuticals, Inc. (United States)
Nutrifynn Caps, Inc. (United States)
Oceans Omega, LLC (United States)
Omega Protein Corp. (United States)
Incon Processing LLC (United States)
Cyvex Nutrition, Inc. (United States)
Organic Technologies (United States)
Originates Inc (United States)
Pharmachem Laboratories, Inc. (United States)
Qualitas Health Inc (United States)
Rimfrost USA, LLC (United States)
Solarvest Bioenergy Inc. (Canada)
Source-Omega LLC (United States)
The Wright Group (United States)
Virun, Inc. (United States)
Wiley's Finest Inc (United States)
Zymes LLC (United States)

2. EUROPE
2.1 European Omega-3 PUFAs Market Analysis by Major Raw Material Source
2.2 European Omega-3 PUFAs Market Overview by Region
2.3 European Omega-3 PUFAs Market Overview by End-Use Application
2.4 Major Market Players
Aker Biomarine AS (Norway)
Arctic Nutrition AS (Norway)
Ayanda AS (Norway)
BASF SE (Germany)
Pronova BioPharma ASA (Norway)
BASF Pharma (Callanish) Limited (United Kingdom)
BASF AS (Norway)
Berg Lipidtech AS (BLT) (Norway)
Biosearch, S.A. (Biosearch Life) (Spain)
Bluebiotech International GmbH (Germany)
BTSA Biotecnologías Aplicadas S.L (Spain)
Copalis (France)
Croda International PLC (United Kingdom)
Denomega Pure Health (Norway)
Epax AS (Norway)
Flavex Naturextrakte GmbH (Germany)
GC Rieber Oils (Norway)
Hofseth Biocare AS (Norway)
IOI Imperial-Oel-Import (Germany)
KD-Pharma GmbH (Germany)
Lonza Group Ltd (Switzerland)
LYSI hf. (Iceland)
Marine Harvest Ingredients (Norway)
Norwegian Fish Oil (Norway)
Olvea Fish Oils (Olvea Group) (France)
Olympic Seafood AS (Norway)
Omegatri AS (Norway)
Omnipharm SAS (France)
Pharma Marine AS (Norway)
Polaris Nutritional Lipids (France)
Royal DSM NV (The Netherlands)
Seven Seas Ltd (United Kingdom)
Simris Alg AB (Sweden)
SMIT Functional Oils (SMIT & Zoon Group) (The Netherlands)
Solutex GC, S.L. (Spain)
Stepan Lipid Nutrition (The Netherlands)
Triplenine Group A/S (Denmark)
Vesteraalens AS (Norway)

3. ASIA-PACIFIC
3.1 Asia-Pacific Omega-3 PUFAs Market Analysis by Raw Material Source
3.2 Asia-Pacific Omega-3 PUFAs Market Overview by Region
3.3 Asia-Pacific Omega-3 PUFAs Market Overview by End-Use Application
3.4 Major Market Players
AK & MN Biofarm Co Ltd (South Korea)
Arjuna Natural Extracts Limited (India)
Avesthagen Limited (India)
Bizen Chemical Co Ltd (Japan)
Chemport, Inc. (Korea)
Coastal Aquatic Proteins (India)
ECA Healthcare Inc (China)
Ennature Biopharma (India)
Fenchem Biotek Ltd (China)
Fujian Coland Enterprises Co Ltd (China)
Guangdong Runke Bioengineering Co Ltd (China)
Hebei Haiyuan Health Biological Science and Technology Co., Ltd. (China)
Huatai Biopharm Inc. (China)
Hubei Fuxing Biotechnology Co Ltd (China)
Jiangsu Auqi Marine Biotechnology Co., Ltd. (China)
Kinomega Biopharm Inc. (China)
Maruha Nichiro Foods Inc. (Japan)
Nippon Suisan Kaisha, Ltd. (Nissui) (Japan)
Nisshin Pharma Inc. (Japan)
Novosana (Taicang) Co. Ltd. (China)
Nu-Mega Ingredients Pty Ltd (Australia)
Parry Nutraceuticals (India)
Photonz Corporation (New Zealand)
Qponics Limited (Australia)
Seadragon Marine Oils Ltd (New Zealand)
Shandong Keruier Biological Products Co (China)
Shandong Yuwang Industry Co Ltd (China)
Sinomega Biotech Engineering Co Ltd (China)
Wuxi Xunda Marine Biological Products Co., Ltd. (China)
Zhejiang Shenzhou Marine Bio-Tech Co Ltd (China)

4. REST OF WORLD
4.1 Rest of World Omega-3 PUFAs Market Analysis by Major Raw Material Source
4.2 Rest of World Omega-3 PUFAs Market Analysis by End-Use Application
4.3 Major Market Players
Enzymotec Ltd. (Israel)
Austral Group S.A.A. (Peru)
Cox & Compañía S.A. (Chile)
Golden Omega SA (Chile)
Natural Oils Chile SA (Chile)
Naturmega SA (Colombia)
Pesquera Camanchaca SA (Chile)
Pesquera Diamante SA (Peru)
Pesquera Hayduk SA (Peru)
Quimica Industrial Spes SA (Spes SA) (Chile)
TASA Omega SA (Tecnológica De Alimentos SA) (Peru)
Vicami SA (Argentina)

PART C: OMEGA-3 PATENT LANDSCAPE
1. Fish Oil Omega-3 Fatty Acids
2. Algal Oil Omega-3 Fatty Acids

PART D: GUIDE TO THE INDUSTRY
1. Manufacturers of Omega 3 Ingredients
2. Pharma Companies in Omega 3 Drugs Market
3. Raw Material Producers, Omega 3 End Users and Other Related Companies in Omega 3 Industry
4. Major Ingredient Distributors

PART E: ANNEXURE
1. RESEARCH METHODOLOGY
2. THE QUESTIONNAIRE
3. FEEDBACK

Charts & Graphs

PART A: GLOBAL MARKET PERSPECTIVE
Chart 1: Global Omega-3 PUFAs Market Overview (2013 & 2020) in Volume (Metric Tons) and Value (US$ Million)
Table 1: Types of polyunsaturated omega-3 fatty acids
Table 2: Dietary Sources of Omega-3 Fatty Acids
Table 3: Alpha-Linolenic Acid Content of Selected Foods and Oils
Table 4: Leading Plant Sources of Alpha-Linolenic Acid (ALA)
Table 5: EPA + DHA Content in Selected Fish and Seafood per 85 Gram Serving
Table 6: Omega-3 Fatty Acids EPA and DHA in Microalgae
Table 7: Forms of Omega-3 Fatty Acid Ingredients
Chart 2: Snapshot for Global Omega3 PUFAs Market Share (2012) by Ingredient Type
Chart 3: Global 18/12 Fish Oil Omega-3 PUFAs Market Analysis (2013 & 2020) by Volume (Metric Tons) and Value (US$ Million)
Chart 4: Global Cod Liver Oil Omega-3 PUFAs Market Analysis (2013 & 2020) by Volume (Metric Tons) and Value (US$ Million)
Chart 5: Global Tuna Oil Omega-3 PUFAs Market Analysis (2013 & 2020) by Volume (Metric Tons) and Value (US$ Million)
Chart 6: Global Salmon Oil Omega-3 PUFAs Market Analysis (2013 & 2020) by Volume (Metric Tons) and Value (US$ Million)
Chart 7: Global Omega-3 Low Concentrate (40% to 55%) PUFAs Market Analysis by Volume (Metric Tons) and Value (US$ Million)
Chart 8: Global Omega-3 Medium Concentrate (60% to 80%) PUFAs Market Analysis by Volume (Metric Tons) and Value (US$ Million)
Chart 9: Global Omega-3 High Concentrate (above 85%) PUFAs Market Analysis by Volume (Metric Tons) and Value (US$ Million)
Chart 10: Global Krill Oil Omega-3 PUFAs Market Analysis (2013 & 2020) by Volume (Metric Tons) and Value (US$ Million)
Chart 11: Global Algal Oil Omega-3 PUFAs Market Analysis by Volume (Metric Tons) and Value (US$ Million)
Chart 12: Global Other Omega-3 PUFAs (Squid/Calamari etc.) Market Analysis by Volume (Metric Tons) and Value (US$ Million)
Chart 13: Snapshot for Global Omega3 PUFAs Market Share (2012) by End-Use Applications
Chart 14: Global Omega-3 PUFAs End-use Application in Dietary Supplements Market Analysis (2013 & 2020) by Volume (Metric Tons) and Value (US$ Million)
Chart 15: Global Omega-3 PUFAs End-use Application in Pet Nutrition Market Analysis (2013 & 2020) by Volume (Metric Tons) and Value (US$ Million)
Chart 16: Global Omega-3 PUFAs End-use Application in Food & Beverages Market Analysis (2013 & 2020) by Volume (Metric Tons) and Value (US$ Million)
Chart 17: Global Omega-3 PUFAs End-use Application in Infant Nutrition Market Analysis (2013 & 2020) by Volume (Metric Tons) and Value (US$ Million)
Chart 18: Global Omega-3 PUFAs End-use Application in Pharmaceuticals Market Analysis (2013 & 2020) by Volume (Metric Tons) and Value (US$ Million)
Chart 19: Global Omega-3 PUFAs End-use Application in Clinical Nutrition Market Analysis (2013 & 2020) by Volume (Metric Tons) and Value (US$ Million)
Table 8: Recommendations for Omega-3 Fatty Acids (EPA and DHA) Intake Globally
Table 9: Quality Specifications and Regulations Related to Omega-3 Oils
Table 10: Commercially available microalgae omega-3 oils
Table 11: Microalgae strains characterized by EPA production
Table 12: Microalgae strains characterized by DHA production
Figure 1: Omega-3 Supply Chain
Chart 20: Global Omega-3 PUFAs Market Share (%) by Manufacturer in US$ Millions in 2012
Table 13: M&A Activity in the Omega-3 Industry
Chart 21: Global Omega-3 PUFAs Installed Capacities (2012 and 2015E) by Country in Metric Tons
Chart 22: Global Omega-3 PUFAs Installed Capacity (2012 and 2015E) by Raw Material Source in Metric Tons
Chart 23: Global Omega-3 PUFAs Installed Capacity (2012 and 2015E) by Raw Material Source and Manufacturer in Metric Tons
Chart 24: Global Fish Oil Omega-3 PUFAs Installed Capacity (2012 and 2015E) by Country in Metric Tons
Chart 25: Global Fish Oil Omega-3 PUFAs Installed Capacity (2012 and 2015E) by Manufacturer in Metric Tons
Chart 26: Global Algal Oil Omega-3 PUFAs Installed Capacity (2012 and 2015E) by Country in Metric Tons
Chart 27: Global Algal Oil Omega-3 PUFAs Installed Capacity (2012 and 2015E) by Manufacturer in Metric Tons
Chart 28: Global Krill Oil Omega-3 PUFAs Installed Capacity (2012 and 2015E) by Country in Metric Tons
Chart 29: Global Krill Oil Omega-3 PUFAs Installed Capacity (2012 and 2015E) by Manufacturer in Metric Tons
Table14: Price Levels of Different Omega-3 PUFAs
Figure 2: Omega-3 PUFA Ingredients and End-use Applications
Figure 3: Omega-3 PUFAs Value Proposition

GLOBAL MARKET OVERVIEW
Chart 30: Global Omega-3 PUFAs Market Analysis (2009-2020) in Volume (Metric Tons) and Value (USD Million)
Chart 31: Global Omega-3 PUFAs Market Overview (2009-2020) by End-use Application – Dietary Supplements, Pet Nutrition, Food & Beverages, Infant Nutrition, Pharmaceuticals and Clinical Nutrition in Metric Tons
Chart 32: Glance at 2010, 2015 and 2020 Global Omega-3 PUFAs Volume Share (%) by End-use Application – Dietary Supplements, Pet Nutrition, Food & Beverages, Infant Nutrition, Pharmaceuticals and Clinical Nutrition
Chart 33: Global Omega-3 PUFAs Market Overview (2009-2020) by End-use Application – Dietary Supplements, Pet Nutrition, Food & Beverages, Infant Nutrition, Pharmaceuticals and Clinical Nutrition in USD Million
Chart 34: Glance at 2010, 2015 and 2020 Global Omega-3 PUFAs Market Share (%) by End-use Application – Dietary Supplements, Pet Nutrition, Food & Beverages, Infant Nutrition, Pharmaceuticals and Clinical Nutrition
Chart 35: Global Omega-3 PUFAs Market Analysis (2009-2020) by Major Raw Material Sources – Marine Oils and Algal Oils in Metric Tons
Chart 36: Glance at 2010, 2015 and 2020 Global Omega-3 PUFAs Volume Share (%) by Major Raw Material Sources – Marine Oils and Algal Oils
Chart 37: Global Omega-3 PUFAs Market Analysis (2009-2020) by Major Raw Material Sources – Marine Oils and Algal Oils in USD Million
Chart 38: Glance at 2010, 2015 and 2020 Global Omega-3 PUFAs Market Share (%) by Major Raw Material Sources – Marine Oils and Algal Oils
Chart 39: Global Omega 3 PUFAs Market Overview (2009-2020) by Product Ingredient Type – 18/12 Fish Oils, Tuna Oils, Cord Liver Oils, Sardine Oils, Low Concentrates (40-60%), Medium Concentrates (70-85%), High Concentrates (>85%), Krill Oils, Algal Oils and Squid Oils in Metric Tons
Chart 40: Glance at 2010, 2015 and 2020 Global Omega 3 PUFAs Volume Share (%) by Product Ingredient Type – 18/12 Fish Oils, Tuna Oils, Cord Liver Oils, Sardine Oils, Low Concentrates (40-60%), Medium Concentrates (70-85%), High Concentrates (>85%), Krill Oils, Algal Oils and Squid Oils
Chart 41: Global Omega 3 PUFAs Market Overview (2009-2010) by Product Ingredient Type – 18/12 Fish Oils, Tuna Oils, Cord Liver Oils, Sardine Oils, Low Concentrates (40-60%), Medium Concentrates (70-85%), High Concentrates (>85%), Krill Oils, Algal Oils and Squid Oils in USD Million
Chart 42: Glance at 2010, 2015 and 2020 Global Omega 3 PUFAs Market Share (%) by Product Ingredient Type – 18/12 Fish Oils, Tuna Oils, Cord Liver Oils, Sardine Oils, Low Concentrates (40-60%), Medium Concentrates (70-85%), High Concentrates (>85%), Krill Oils, Algal Oils and Squid Oils

PART B: REGIONAL MARKET PERSPECTIVE
Chart 43: Global Omega-3 PUFAs Market Overview (2009-2020) by Geographic Region – North America, Europe, Asia-Pacific and Rest of World in Metric Tons
Chart 44: Glance at 2010, 2015 and 2020 Global Omega-3 PUFAs Volume Share (%) by Geographic Region – North America, Europe, Asia-Pacific and Rest of World
Chart 45: Global Omega-3 PUFAs Market Overview (2009-2020) by Geographic Region – North America, Europe, Asia-Pacific and Rest of World in USD Million
Chart 46: Glance at 2010, 2015 and 2020 Global Omega-3 PUFAs Market Share (%) by Geographic Region – North America, Europe, Asia-Pacific and Rest of World
Chart 47: Global Marine Oil Omega-3 PUFAs Market Analysis (2009-2020) by Geographic Region – North America, Europe, Asia-Pacific and Rest of World in Metric Tons
Chart 48: Glance at 2010, 2015 and 2020 Global Marine Oil Omega-3 PUFAs Volume Share (%) by Geographic Region – North America, Europe, Asia-Pacific and Rest of World
Chart 49: Global Marine Oil Omega-3 PUFAs Market Analysis (2009-2020) by Geographic Region – North America, Europe, Asia-Pacific and Rest of World in USD Million
Chart 50: Glance at 2010, 2015 and 2020 Global Marine Oil Omega-3 PUFAs Market Share (%) by Geographic Region – North America, Europe, Asia-Pacific and Rest of World
Chart 51: Global Algal Oil Omega-3 PUFAs Market Analysis (2009-2020) by Geographic Region – North America, Europe, Asia-Pacific and Rest of World in Metric Tons
Chart 52: Glance at 2010, 2015 and 2020 Global Algal Oil Omega-3 PUFAs Volume Share (%) by Geographic Region – North America, Europe, Asia-Pacific and Rest of World
Chart 53: Global Algal Oil Omega-3 PUFAs Market Analysis (2009-2020) by Geographic Region – North America, Europe, Asia-Pacific and Rest of World in USD Million
Chart 54: Glance at 2010, 2015 and 2020 Global Algal Oil Omega-3 PUFAs Market Share (%) by Geographic Region - North America, Europe, Asia-Pacific and Rest of World
Chart 55: Global Omega-3 PUFAs End-use Application in Dietary Supplements Market Analysis (2009-2020) by Geographic Region – North America, Europe, Asia-Pacific and Rest of World in Metric Tons
Chart 56: Glance at 2010, 2015 and 2020 Global Omega-3 PUFAs End-use Application in Dietary Supplements Volume Share (%) by Geographic Region – North America, Europe, Asia-Pacific and Rest of World
Chart 57: Global Omega-3 PUFAs End-use Application in Dietary Supplements Market Analysis (2009-2020) by Geographic Region – North America, Europe, Asia-Pacific and Rest of World in USD Million
Chart 58: Glance at 2010, 2015 and 2020 Global Omega-3 PUFAs End-use Application in Dietary Supplements Market Share (%) by Geographic Region – North America, Europe, Asia-Pacific and Rest of World
Chart 59: Global Omega-3 PUFAs End-use Application in Pet Nutrition Market Analysis (2009-2020) by Geographic Region – North America, Europe, Asia-Pacific and Rest of World in Metric Tons
Chart 60: Glance at 2010, 2015 and 2020 Global Omega-3 PUFAs End-use Application in Pet Nutrition Volume Share (%) by Geographic Region – North America, Europe, Asia-Pacific and Rest of World
Chart 61: Global Omega-3 PUFAs End-use Application in Pet Nutrition Market Analysis (2009-2020) by Geographic Region – North America, Europe, Asia-Pacific and Rest of World in USD Million
Chart 62: Glance at 2010, 2015 and 2020 Global Omega-3 PUFAs End-use Application in Pet Nutrition Market Share (%) by Geographic Region – North America, Europe, Asia-Pacific and Rest of World
Chart 63: Global Omega-3 PUFAs End-use Application in Food & Beverages Market Analysis (2009-2020) by Geographic Region – North America, Europe, Asia-Pacific and Rest of World in Metric Tons
Chart 64: Glance at 2010, 2015 and 2020 Global Omega-3 PUFAs End-use Application in Food & Beverages Volume Share (%) by Geographic Region – North America, Europe, Asia-Pacific and Rest of World
Chart 65: Global Omega-3 PUFAs End-use Application in Food & Beverages Market Analysis (2009-2020) by Geographic Region – North America, Europe, Asia-Pacific and Rest of World in USD Million
Chart 66: Glance at 2010, 2015 and 2020 Global Omega-3 PUFAs End-use Application in Food & Beverages Market Share (%) by Geographic Region –North America, Europe, Asia-Pacific and Rest of World
Chart 67: Global Omega-3 PUFAs End-use Application in Infant Nutrition Market Analysis (2009-2020) by Geographic Region –North America, Europe, Asia-Pacific and Rest of World in Metric Tons
Chart 68: Glance at 2010, 2015 and 2020 Global Omega-3 PUFAs End-use Application in Infant Nutrition Volume Share (%) by Geographic Region – North America, Europe, Asia-Pacific and Rest of World
Chart 69: Global Omega-3 PUFAs End-use Application in Infant Nutrition Market Analysis (2009-2020) by Geographic Region – North America, Europe, Asia-Pacific and Rest of World in USD Million
Chart 70: Glance at 2010, 2015 and 2020 Global Omega-3 PUFAs End-use Application in Infant Nutrition Market Share (%) by Geographic Region – North America, Europe, Asia-Pacific and Rest of World
Chart 71: Global Omega-3 PUFAs End-use Application in Pharmaceuticals Market Analysis (2009-2020) by Geographic Region – North America, Europe, Asia-Pacific and Rest of World in Metric Tons
Chart 72: Glance at 2010, 2015 and 2020 Global Omega-3 PUFAs End-use Application in Pharmaceuticals Volume Share (%) by Geographic Region – North America, Europe, Asia-Pacific and Rest of World
Chart 73: Global Omega-3 PUFAs End-use Application in Pharmaceuticals Market Analysis (2009-2020) by Geographic Region – North America, Europe, Asia-Pacific and Rest of World in USD Million
Chart 74: Glance at 2010, 2015 and 2020 Global Omega-3 PUFAs End-use Application in Pharmaceuticals Market Share (%) by Geographic Region – North America, Europe, Asia-Pacific and Rest of World
Chart 75: Global Omega-3 PUFAs End-use Application in Clinical Nutrition Market Analysis (2009-2020) by Geographic Region – North America, Europe, Asia-Pacific and Rest of World in Metric Tons
Chart 66: Glance at 2010, 2015 and 2020 Global Omega-3 PUFAs End-use Application in Clinical Nutrition Volume Share (%) by Geographic Region – North America, Europe, Asia-Pacific and Rest of World
Chart 77: Global Omega-3 PUFAs End-use Application in Clinical Nutrition Market Analysis (2009-2020) by Geographic Region – North America, Europe, Asia-Pacific and Rest of World in USD Million
Chart 78: Glance at 2010, 2015 and 2020 Global Omega-3 PUFAs End-use Application in Clinical Nutrition Market Share (%) by Geographic Region – North America, Europe, Asia-Pacific and Rest of World

REGIONAL MARKET OVERVIEW

NORTH AMERICA
Chart 79: North American Omega-3 PUFAs Market Overview (2009-2020) by Volume (Metric Tons) and Value (US$ Million)
Chart 80: North American Omega-3 PUFAs Market Analysis (2009-2020) by Major Raw Material Source – Marine Oils and Algal Oils in Metric Tons
Chart 81: Glance at 2010, 2015 and 2020 North American Omega-3 PUFAs Volume Share (%) by Majo


To order this report: Omega-3 Polyunsaturated Fatty Acids (PUFAs) - A Global Market Overview
http://www.reportlinker.com/p02029889/Omega-3-Polyunsaturated-Fatty-Acids-PUFAs---A-Global-Market-Overview.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Pharmaceutical

Contact Clare: [email protected]
US: (339)-368-6001
Intl: +1 339-368-6001

 

SOURCE Reportlinker

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
As many know, the first generation of Cloud Management Platform (CMP) solutions were designed for managing virtual infrastructure (IaaS) and traditional applications. But that's no longer enough to satisfy evolving and complex business requirements. In his session at 21st Cloud Expo, Scott Davis, Embotics CTO, explored how next-generation CMPs ensure organizations can manage cloud-native and microservice-based application architectures, while also facilitating agile DevOps methodology. He expla...
SYS-CON Events announced today that Synametrics Technologies will exhibit at SYS-CON's 22nd International Cloud Expo®, which will take place on June 5-7, 2018, at the Javits Center in New York, NY. Synametrics Technologies is a privately held company based in Plainsboro, New Jersey that has been providing solutions for the developer community since 1997. Based on the success of its initial product offerings such as WinSQL, Xeams, SynaMan and Syncrify, Synametrics continues to create and hone in...
To get the most out of their data, successful companies are not focusing on queries and data lakes, they are actively integrating analytics into their operations with a data-first application development approach. Real-time adjustments to improve revenues, reduce costs, or mitigate risk rely on applications that minimize latency on a variety of data sources. In his session at @BigDataExpo, Jack Norris, Senior Vice President, Data and Applications at MapR Technologies, reviewed best practices t...
"Evatronix provides design services to companies that need to integrate the IoT technology in their products but they don't necessarily have the expertise, knowledge and design team to do so," explained Adam Morawiec, VP of Business Development at Evatronix, in this SYS-CON.tv interview at @ThingsExpo, held Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA.
DevOps promotes continuous improvement through a culture of collaboration. But in real terms, how do you: Integrate activities across diverse teams and services? Make objective decisions with system-wide visibility? Use feedback loops to enable learning and improvement? With technology insights and real-world examples, in his general session at @DevOpsSummit, at 21st Cloud Expo, Andi Mann, Chief Technology Advocate at Splunk, explored how leading organizations use data-driven DevOps to clos...
"I focus on what we are calling CAST Highlight, which is our SaaS application portfolio analysis tool. It is an extremely lightweight tool that can integrate with pretty much any build process right now," explained Andrew Siegmund, Application Migration Specialist for CAST, in this SYS-CON.tv interview at 21st Cloud Expo, held Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA.
Recently, REAN Cloud built a digital concierge for a North Carolina hospital that had observed that most patient call button questions were repetitive. In addition, the paper-based process used to measure patient health metrics was laborious, not in real-time and sometimes error-prone. In their session at 21st Cloud Expo, Sean Finnerty, Executive Director, Practice Lead, Health Care & Life Science at REAN Cloud, and Dr. S.P.T. Krishnan, Principal Architect at REAN Cloud, discussed how they built...
The dynamic nature of the cloud means that change is a constant when it comes to modern cloud-based infrastructure. Delivering modern applications to end users, therefore, is a constantly shifting challenge. Delivery automation helps IT Ops teams ensure that apps are providing an optimal end user experience over hybrid-cloud and multi-cloud environments, no matter what the current state of the infrastructure is. To employ a delivery automation strategy that reflects your business rules, making r...
The past few years have brought a sea change in the way applications are architected, developed, and consumed—increasing both the complexity of testing and the business impact of software failures. How can software testing professionals keep pace with modern application delivery, given the trends that impact both architectures (cloud, microservices, and APIs) and processes (DevOps, agile, and continuous delivery)? This is where continuous testing comes in. D
Modern software design has fundamentally changed how we manage applications, causing many to turn to containers as the new virtual machine for resource management. As container adoption grows beyond stateless applications to stateful workloads, the need for persistent storage is foundational - something customers routinely cite as a top pain point. In his session at @DevOpsSummit at 21st Cloud Expo, Bill Borsari, Head of Systems Engineering at Datera, explored how organizations can reap the bene...
No hype cycles or predictions of a gazillion things here. IoT is here. You get it. You know your business and have great ideas for a business transformation strategy. What comes next? Time to make it happen. In his session at @ThingsExpo, Jay Mason, an Associate Partner of Analytics, IoT & Cybersecurity at M&S Consulting, presented a step-by-step plan to develop your technology implementation strategy. He also discussed the evaluation of communication standards and IoT messaging protocols, data...
In a recent survey, Sumo Logic surveyed 1,500 customers who employ cloud services such as Amazon Web Services (AWS), Microsoft Azure, and Google Cloud Platform (GCP). According to the survey, a quarter of the respondents have already deployed Docker containers and nearly as many (23 percent) are employing the AWS Lambda serverless computing framework. It’s clear: serverless is here to stay. The adoption does come with some needed changes, within both application development and operations. Tha...
Digital transformation is about embracing digital technologies into a company's culture to better connect with its customers, automate processes, create better tools, enter new markets, etc. Such a transformation requires continuous orchestration across teams and an environment based on open collaboration and daily experiments. In his session at 21st Cloud Expo, Alex Casalboni, Technical (Cloud) Evangelist at Cloud Academy, explored and discussed the most urgent unsolved challenges to achieve f...
With tough new regulations coming to Europe on data privacy in May 2018, Calligo will explain why in reality the effect is global and transforms how you consider critical data. EU GDPR fundamentally rewrites the rules for cloud, Big Data and IoT. In his session at 21st Cloud Expo, Adam Ryan, Vice President and General Manager EMEA at Calligo, examined the regulations and provided insight on how it affects technology, challenges the established rules and will usher in new levels of diligence arou...
In his general session at 21st Cloud Expo, Greg Dumas, Calligo’s Vice President and G.M. of US operations, discussed the new Global Data Protection Regulation and how Calligo can help business stay compliant in digitally globalized world. Greg Dumas is Calligo's Vice President and G.M. of US operations. Calligo is an established service provider that provides an innovative platform for trusted cloud solutions. Calligo’s customers are typically most concerned about GDPR compliance, application p...